BASF SE officially ended its efforts to acquire Evonik Industries AG (Evonik) after the German chemical company rejected two non-binding, all-cash acquisition offers. The decision reflects BASF’s commitment to disciplined capital allocation and its focus on creating long-term shareholder value. Although BASF indicated its willingness to consider a further moderate increase in its offer, Evonik’s Executive Board had not demonstrated meaningful engagement. At the same time, BASF’s assessment of Evonik’s standalone business prospects and associated risks did not support a higher valuation. Consequently, BASF concluded that pursuing the acquisition at a higher price would not serve the best interests of its shareholders.
BASF Withdraws Acquisition Offers for Evonik
BASF’s decision follows the rejection of two non-binding, all-cash proposals by Evonik. The company had offered €24 per share, which BASF believed would deliver significant additional value to Evonik shareholders. Despite remaining open to a moderate increase in its proposal, BASF did not receive the level of engagement required to move the potential transaction forward. Furthermore, BASF evaluated Evonik’s standalone growth prospects and the risks associated with the proposed acquisition. Following this assessment, the company determined that a higher offer could not be justified from a financial and strategic perspective.
BASF Highlights Potential Benefits of the Proposed Combination
Commenting on the decision, Dr. Markus Kamieth, Chairman of the Board of Executive Directors of BASF SE, emphasized the value that the proposed transaction could have generated for both companies. He stated that BASF remained convinced that its derisked, all-cash offer of €24 per share would have created significant additional value for Evonik shareholders. Kamieth also reiterated BASF’s belief that bringing the two businesses together under BASF’s ownership could have created a stronger and more competitive chemical company. In addition, the proposed combination could have generated further benefits for shareholders, employees, and customers by strengthening the combined company’s market position and business capabilities.
BASF Reaffirms Its Disciplined Capital Allocation Strategy
The decision to end the Evonik acquisition pursuit aligns with BASF’s broader Winning Ways corporate strategy. Under this strategy, BASF has consistently maintained that acquisitions represent an opportunity to strengthen and expand its core businesses rather than an essential requirement for achieving growth. By withdrawing from the proposed transaction, BASF has reinforced its commitment to evaluating investment opportunities carefully and maintaining financial discipline. Moreover, the company intends to prioritize attractive shareholder distributions while focusing on strategic investments that support its long-term business objectives.
Focus Remains on Core Business Growth and Shareholder Returns
BASF’s decision to end discussions with Evonik highlights its selective approach to mergers and acquisitions. Rather than pursuing a transaction at an increased valuation, the company has chosen to maintain its capital allocation discipline and protect shareholder interests. Going forward, BASF will continue to focus on strengthening its core businesses, pursuing value-creating growth opportunities, and delivering attractive returns to shareholders. As per BASF press release, the development underscores the company’s position that strategic acquisitions must offer clear financial and operational benefits to justify the investment.




